Scaffold Biomaterial for Neuropathy
Trial Summary
What is the purpose of this trial?
This is safety study. Subjects will be undergoing the surgical procedure of nerve biopsy. After routine surgery without grafting, patients develop swelling, redness, tenderness and dysesthesia at the biopsy site. In order to determine whether grafting is safe compared to not repairing the nerve, it is necessary to compare treated vs. untreated patients using systematic, sensitive and reproducible criteria.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Biopsy + Nerve Repair, Biopsy Only for neuropathy?
Research shows that using bioresorbable materials and neural scaffolds can help nerve regeneration, which is important for treating nerve damage. These materials have been used successfully in animal studies to support nerve healing, suggesting they might be helpful in similar human treatments.12345
Is the scaffold biomaterial for neuropathy safe for humans?
The safety of nerve guidance conduits and wraps, which are similar to scaffold biomaterials, has been reviewed and approved by the FDA for peripheral nerve repair. These materials, made from both natural and synthetic substances, have been evaluated for safety in clinical settings, indicating they are generally safe for human use.12678
How is the treatment Biopsy + Nerve Repair unique for treating neuropathy?
This treatment is unique because it uses a scaffold biomaterial, which is a structure that supports nerve regeneration, potentially offering a more effective alternative to traditional nerve grafts. The use of biomimetic (nature-inspired) scaffolds can enhance nerve repair by mimicking the natural environment of nerves, which may improve healing outcomes compared to standard treatments.124910
Research Team
Anthony J Windebank, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for adults aged 18-75 with certain nerve conditions who need a sural nerve biopsy and can follow the study plan. They must have a specific level of nerve signal strength, not smoke, and not be pregnant or breastfeeding. People with recent major heart issues, immune disorders (except thyroid conditions), previous trauma at the biopsy site, or infections like MRSA are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo the surgical procedure of nerve biopsy with or without nerve repair
Post-Surgery Monitoring
Participants are monitored for post-surgical reactions and safety, including physical/neurological exams and sural nerve ultrasonography
Long-term Follow-up
Participants are monitored for safety and effectiveness, including assessments of neuroma formation and sensory nerve regeneration
Treatment Details
Interventions
- Biopsy + Nerve Repair
- Biopsy Only
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor